Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

A Beceiro, M Tomás, G Bou - Clinical microbiology reviews, 2013 - Am Soc Microbiol
Hosts and bacteria have coevolved over millions of years, during which pathogenic bacteria
have modified their virulence mechanisms to adapt to host defense systems. Although the …

Accelerating next-generation vaccine development for global disease prevention

WC Koff, DR Burton, PR Johnson, BD Walker, CR King… - Science, 2013 - science.org
Background Vaccines have provided some of the greatest successes in the history of
medicine, including the eradication of smallpox, the near eradication of polio, and the …

The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination

M Vono, M Taccone, P Caccin… - Proceedings of the …, 2013 - National Acad Sciences
Vaccines are the most effective agents to control infections. In addition to the pathogen
antigens, vaccines contain adjuvants that are used to enhance protective immune …

Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century

GA Poland, RB Kennedy, BA McKinney… - Seminars in …, 2013 - Elsevier
Vaccines, like drugs and medical procedures, are increasingly amenable to individualization
or personalization, often based on novel data resulting from high throughput “omics” …

A maternal vaccine against group B Streptococcus: past, present, and future

VL Chen, FY Avci, DL Kasper - Vaccine, 2013 - Elsevier
Abstract Group B Streptococcus (GBS) is a major cause of morbidity and mortality among
neonates. Though there have been tremendous advances in prevention of invasive …

[HTML][HTML] Genome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinology

Z Xiang, Y He - BMC bioinformatics, 2013 - Springer
Herpes simplex virus (HSV) types 1 and 2 (HSV-1 and HSV-2) are the most common
infectious agents of humans. No safe and effective HSV vaccines have been licensed …

[HTML][HTML] Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)

JA Bettinger, DW Scheifele, SA Halperin, W Vaudry… - Vaccine, 2013 - Elsevier
Background In collaboration with the Canadian Immunization Monitoring Program Active
(IMPACT), the National Microbiology Laboratory, the UK Health Protection Agency and …

[HTML][HTML] Jenner-predict server: prediction of protein vaccine candidates (PVCs) in bacteria based on host-pathogen interactions

V Jaiswal, SK Chanumolu, A Gupta, RS Chauhan… - BMC …, 2013 - Springer
Background Subunit vaccines based on recombinant proteins have been effective in
preventing infectious diseases and are expected to meet the demands of future vaccine …

[HTML][HTML] Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis

G Gomez, LG Adams, A Rice-Ficht… - Frontiers in cellular and …, 2013 - frontiersin.org
Vaccination is the most important approach to counteract infectious diseases. Thus, the
development of new and improved vaccines for existing, emerging, and re-emerging …

[HTML][HTML] Immunogenic and Invasive Properties of Brucella melitensis 16M Outer Membrane Protein Vaccine Candidates Identified via a Reverse Vaccinology …

G Gomez, J Pei, W Mwangi, LG Adams, A Rice-Ficht… - PloS one, 2013 - journals.plos.org
Brucella is the etiologic agent of brucellosis, one of the most common and widely distributed
zoonotic diseases. Its highly infectious nature, the insidious, systemic, chronic, debilitating …